MARATTO

article · Egyptian Retina Journal

Paracentral Acute Middle Maculopathy after Isotretinoin

20222 citationsOpen accessKafr el-Sheikh University

Abstract

Paracentral acute middle maculopathy (PAMM) can be caused by a variety of retinal, ocular, iatrogenic, and systemic factors. Patients with PAMM typically have a sudden onset of paracentral scotomata, difficulty focusing, and/or blurred central vision. Isotretinoin is associated with multiple ocular side effects, including eye dryness and loss of night vision. In this study, we present a case of PAMM after 13 months of isotretinoin treatment with no evidence of other causes or relevant medical history.

Research topics

  • Retinal and Optic Conditions
  • Drug-Induced Ocular Toxicity
  • Ocular Diseases and Behçet’s Syndrome

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4103/erj.erj_2_23

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.